KYMR - Kymera Therapeutics, Inc.
83.52
-2.590 -3.101%
Share volume: 1,044,442
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$86.11
-2.59
-0.03%
Summary score
34%
Profitability
35%
Dept financing
22%
Liquidity
58%
Performance
31%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.62%
Return on assets
-6.66%
Return on sales
-954.7%
Return on invested capital
-54.72%
Total debt ratio
19.82%
Debt ratio change over timeo
-1.62%
Current Ratio
7.04%
Quick Ratio
5.65%
Cash Position Ratio
3.8%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-6.53%
Return on sales
-2364.64%
Return on invested capital
0%
Total debt ratio
12.63%
Debt ratio change over timeo
0%
Current Ratio
8.78%
Quick Ratio
0%
Cash Position Ratio
2.46%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-4.99%
Return on sales
-3409.79%
Return on invested capital
0%
Total debt ratio
9.36%
Debt ratio change over time
0%
Current Ratio
10.47%
Quick Ratio
0%
Cash Position Ratio
4.29%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-80.1%
Return on assets
-81.93%
Return on sales
1244.75%
Return on invested capital
-0.26%
Total debt ratio
-161.73%
Debt ratio change over time
-1.62%
Current Ratio
-18.79%
Quick Ratio
-13.96%
Cash Position Ratio
-13.13%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KYMR | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -8.62% | 0% | 5.97% | 8.91% |
| Return on assets | -6.66% | 2.97% | 3.34% | 2.04% |
| Return on sales | -954.7% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | -54.72% | 0% | 3.51% | 10.25% |
| Profitability | 0% | 47% | 75% | 85% |
| Total debt ratio | 19.82% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | -1.62% | 14.34% | 187.33% | 9.75% |
| Dept financing | 5% | 27% | 43% | 13% |
| Current Ratio | 8.78% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 2.46% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 17% | 14% | 20% |
| Short-term ratios | KYMR | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -6.53% | 3.27% | 4.7% | 1.36% |
| Return on sales | -2364.64% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 12.63% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 25% | 18% | 10% |
| Current Ratio | 8.78% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 2.46% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 21% | 28% | 40% |